LAURA HERINGER: Open Payments
NPI 1912140278 · DEMOREST, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$289 in 13 payments from 9 companies in 2025. Trend: 2023 $104 · 2024 $201 · 2025 $289
Food & beverage: $289
| Company | Payments | Amount |
|---|---|---|
| Eisai Inc. | 2 | $54 |
| Radius Health, Inc. | 2 | $42 |
| Lilly USA, LLC | 2 | $42 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $40 |
| Novo Nordisk Inc | 1 | $33 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $21 |
| Exact Sciences Corporation | 1 | $21 |
| ACADIA Pharmaceuticals Inc | 1 | $19 |
| Otsuka America Pharmaceutical, Inc. | 1 | $18 |
Products named: Leqembi, Tymlos, MOUNJARO, XIFAXAN, Ozempic, JOURNAVX, The Cologuard Plus Collection Kit, NUPLAZID.
Industry payments across GA — which companies pay providers there.
